{"id":1467,"date":"2018-03-14T14:36:41","date_gmt":"2018-03-14T19:36:41","guid":{"rendered":"https:\/\/pharmgate.com\/?page_id=1467"},"modified":"2025-10-17T19:22:33","modified_gmt":"2025-10-17T19:22:33","slug":"aivlosin-17","status":"publish","type":"page","link":"https:\/\/pharmgate.com\/canada\/aivlosin-17\/","title":{"rendered":"Aivlosin 17%"},"content":{"rendered":"\n<h1>\n\t\tAIVLOSIN<sup>\u00ae<\/sup> 17%\n\t<\/h1>\n\t<h3>(Tylvalosin Medicated Premix)<br \/>Veterinary use only<\/h3>\n\t\t\t\t<img decoding=\"async\" src=\"https:\/\/pharmgate.com\/wp-content\/uploads\/2018\/01\/Aivlosin-species-577x75.png\" alt=\"Aivlosin-species-577x75\" itemprop=\"image\" title=\"Aivlosin-species-577x75\" onerror=\"this.style.display='none'\"  \/>\n\t\t\t<a href=\"\/canada\/wp-content\/uploads\/sites\/3\/2018\/08\/AIVLOSIN-17_Canada-Product-Profile-Sheet-1089.0518-8.27.18.pdf\" target=\"_blank\" rel=\"noopener\">\n\t\t\t\t\t\tProduct Profile\n\t\t\t\t\t<\/a>\n\t\t\t<a href=\"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2025\/10\/AIVLOSIN\u00ae-17-Tylvalosin-Type-A-Medicated-Article-Premix-US-EN-8-sds.pdf\" target=\"_blank\" rel=\"noopener\">\n\t\t\t\t\t\tSafety Data Sheet\n\t\t\t\t\t<\/a>\n\t\t\t<a href=\"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2025\/10\/AIVLOSIN\u00ae-17-Tylvalosin-Type-A-Medicated-Article-Premix-FR-FR-8-sds.pdf\" target=\"_blank\" rel=\"noopener\">\n\t\t\t\t\t\tSafety Data Sheet (FR)\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<h4>Product Description<\/h4>\n\t\t\t<ul>\n<li>Aivlosin\u00ae 17% contains 170 g\/kg tylvalosin\u00a0(supplied as tylvalosin tartrate) for oral use in\u00a0medicating complete feed for swine<\/li>\n<li>For the treatment of Porcine Proliferative Enteropathy (PPE)\u00a0associated with\u00a0<em>Lawsonia intracellularis\u00a0<\/em>in pigs<\/li>\n<li>Tylvalosin, the active ingredient in Aivlosin 17%, is a macrolide antibiotic<\/li>\n<li>Free-flowing granules<\/li>\n<li>Veterinary use only<\/li>\n<li>10 kg bags<\/li>\n<\/ul>\n\t\t\t\t\t\t<h4>Key Features<\/h4>\n\t\t\t<ul>\n<li>For the treatment of Porcine Proliferative Enteropathy (PPE)\/ileitis associated with\u00a0<em>Lawsonia intracellularis<\/em>\u00a0infection in pigs<\/li>\n<li>Broad spectrum, potent macrolide not used in human health<\/li>\n<li>Accumulates rapidly in target tissues with intracellular concentrations many times extracellular levels<\/li>\n<li>Reliable dosing, consistent mixing<\/li>\n<li>Requires a prescription from a veterinarian<\/li>\n<li>No withdrawal period is required when treated according to the label<\/li>\n<li>Wide safety margin<\/li>\n<\/ul>\n\t\t\t\t\t\t<h4>Label Indications and Dosage<\/h4>\n\t\t\t<div class=\"fl-builder-content fl-builder-content-6899 fl-builder-template fl-builder-module-template fl-builder-global-templates-locked\" data-post-id=\"6899\"><div class=\"fl-module fl-module-advanced-accordion fl-node-5ltcbv97do3z\" data-node=\"5ltcbv97do3z\">\n\t<div class=\"fl-module-content fl-node-content\">\n\t\t\r\n<div class=\"uabb-module-content uabb-adv-accordion \r\n\t\t\t\t\t\tuabb-adv-accordion-collapse\" data-enable_first=\"no\" role=\"tablist\" >\r\n\t\t<div class=\"uabb-adv-accordion-item\"\r\n\t\t\tdata-index=\"0\">\r\n\t\t<div class=\"uabb-adv-accordion-button uabb-adv-accordion-button5ltcbv97do3z uabb-adv-before-text\" aria-selected=\"false\" role=\"tab\" tabindex=\"0\" aria-expanded=\"true\" aria-controls=\"expandable\">\r\n\t\t\t<div class=\"uabb-adv-accordion-icon-wrap\" ><i class=\"uabb-adv-accordion-button-icon ua-icon ua-icon-plus\"><\/i><\/div>\t\t\t<div class=\"uabb-adv-accordion-button-label\" >Swine<\/div>\r\n\t\t\t\t\t<\/div>\r\n\t\t<div class=\"uabb-adv-accordion-content uabb-adv-accordion-content5ltcbv97do3z fl-clearfix uabb-accordion-desc uabb-text-editor\" aria-expanded=\"true\" >\r\n\t\t\t<p><strong>For Swine:<\/strong>\u00a0Treatment of Porcine Proliferative\u00a0Enteropathy (PPE) associated with\u00a0<em>Lawsonia intracellularis<\/em>\u00a0infection in\u00a0pigs.<\/p>\n<p><strong>WARNINGS:<\/strong><strong><br \/><\/strong>No withdrawal period is required when treated according to the label. Tylvalosin has been shown to cause hypersensitivity reactions in laboratory animals; therefore, people with known hypersensitivity to tylvalosin tartrate should avoid contact with this product.<br \/>When mixing and handling Aivlosin\u00ae 17%, avoid inhalation, oral exposure and direct contact with skin or eyes. Keep out of reach of children.<\/p>\n<p><strong>DESCRIPTION:<\/strong><strong><br \/><\/strong>Aivlosin\u00ae 17% contains 170 g\/kg tylvalosin (supplied as tylvalosin tartrate) for oral use in medicating complete feed for swine.<\/p>\n<p><strong>THERAPEUTIC CLASSIFICATION:<\/strong><strong><br \/><\/strong>Tylvalosin, the active ingredient in Aivlosin 17%, is a macrolide antibiotic.<\/p>\n<p><strong>INDICATIONS:<\/strong><strong><br \/><\/strong>For the treatment of Porcine Proliferative Enteropathy (PPE) associated with\u00a0<em>Lawsonia intracellularis<\/em>\u00a0in pigs.<\/p>\n<p><strong>TARGET SPECIES:\u00a0<\/strong>Pigs.<\/p>\n<p><strong>DOSAGE AND ADMINISTRATION:<\/strong><strong><br \/><\/strong><em>To reduce the development of antimicrobial resistance and maintain effectiveness, use this antibiotic prudently.<\/em><br \/>For Feed Manufacturing Use Only.<br \/>Do not feed undiluted.<br \/>Aivlosin\u00ae 17% must be thoroughly mixed into feeds before use.<br \/>Thoroughly mix 0.25 kg Aivlosin\u00ae 17% with 999.75 kg of complete feed to obtain a medicated feed with tylvalosin concentration of 0.00425% (42.5 g\/1000 kg).<br \/>To aid in the even distribution of drug in the finished feed, add the full amount of Aivlosin\u00ae 17% into a small portion of the feed (at least 10 kg per tonne of finished feed) and mix. Blend this mixture into the remainder of the feed and mix thoroughly. Feed as the sole ration for 14 consecutive days.<\/p>\n<p><strong>CAUTIONS:\u00a0<\/strong>Not for use in breeding animals.<br \/>The effects of tylvalosin on male and female reproductive performance, including pregnancy and lactation, have not been determined.<br \/>Do not use in feeds containing pellet binding agents with the exception of Lignosol (4%) and Agri-Colloid (0.3%).<br \/>Do not use in feeds containing bentonite.<br \/>Acute cases and severely diseased pigs with reduced food and water intake should be treated with a suitable injectable product. It is sound clinical practice to base treatment on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of target bacteria. Use of the product deviating from the instructions may increase the risk of development and selection of resistant bacteria and decrease the effectiveness of treatment with other macrolides due to the potential for cross-resistance.<\/p>\n<p><strong>ADVERSE REACTIONS:<\/strong><strong><br \/><\/strong>No adverse reactions related to the drug were observed during clinical or target animal safety trials.<\/p>\n<p>The Safety Data Sheet contains more detailed occupational safety information.<\/p>\n<p>\u00a0<\/p>\n\t\t<\/div>\r\n\t<\/div>\r\n\t<\/div>\r\n\t<\/div>\n<\/div>\n<\/div><div class=\"uabb-js-breakpoint\" style=\"display: none;\"><\/div>\t\t\n\t\t\t\t\t\t<h4>Withdrawal Period<\/h4>\n\t\t\t<ul>\n<li>No withdrawal period is required when treated according to the label<\/li>\n<\/ul>\n\t\t\t\t\t\t<h4>Packaging<\/h4>\n\t\t\t<ul>\n<li>10 kg (22.07 lbs)<\/li>\n<\/ul>\n\t\t\t\t\t\t<h4>Formulation<\/h4>\n\t\t\t<ul>\n<li>Free-flowing granules.<\/li>\n<li>Formulated for optimal dispersion, segregation, and stability in feed.<\/li>\n<\/ul>\n\t\t\t\t\t\t<h4>Storage<\/h4>\n\t\t\t<ul>\n<li>Store in a cool dry place at or below 25\u00baC.<\/li>\n<\/ul>\n\t\t\t\t\t\t<h5>Swine<\/h5>\n\t\t\t<p><strong>Caution:\u00a0<\/strong>Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.<\/p>\n<p><strong>For Swine:<\/strong>\u00a0Control of porcine proliferative\u00a0enteropathy (PPE) associated with\u00a0<em>Lawsonia intracellularis<\/em>\u00a0infection in\u00a0groups of swine in buildings experiencing\u00a0an outbreak of PPE.<\/p>\n<p><strong>Feeding Directions:\u00a0<\/strong>Feed Type C medicated feed containing 38.6 grams tylvalosin\/ton as the sole ration for 14 consecutive days.<\/p>\n<p><strong>Caution:<\/strong>\u00a0To assure both food safety and responsible use in swine, concurrent use of tylvalosin Type A medicated article in medicated feed and tylvalosin or another macrolide in medicated drinking water or by any other route of administration should be avoided. Not for use in swine intended for breeding. The effects of tylvalosin on swine reproductive performance, pregnancy, and lactation have not been determined. VFDs for tylvalosin shall not be refilled.<\/p>\n<p><strong>Mixing Directions:<br \/><\/strong><strong>\u00a0<\/strong><br \/><strong>Preparation of Type B medicated feed containing 3,856 grams per ton (4,250 ppm) tylvalosin:\u00a0<\/strong>Prepare tylvalosin Type B medicated feed in mash form only.\u00a0To manufacture one ton of Type B medicated feed containing 3,856 g\/ton (4,250 ppm) tylvalosin, mix 50 pounds of Aivlosin \u00ae 17% Type A Medicated Article with 1950 pounds of non-medicated feed.<\/p>\n<p><strong>Preparation of Type C medicated feed containing 38.6 grams per ton (42.5 ppm) tylvalosin:\u00a0<\/strong>To manufacture one ton of Type C medicated feed containing 38.6 g\/ton (42.5 ppm) tylvalosin, mix 0.5 pound of Aivlosin\u00ae 17% Type A Medicated Article with 1999.5 pounds of non-medicated feed.\u00a0To aid in the even distribution of drug in the finished feed, add the full amount of Aivlosin\u00ae 17% Type A Medicated Article into a small\u00a0portion of the feed and mix. Blend this mixture into the remainder of the feed and mix thoroughly.<\/p>\n<p>Pelleted Type C medicated feeds must bear an expiration date of 30 days after the date of manufacture.<\/p>\n<p>Crumbled Type C medicated feeds must bear an expiration date of 7 days after the date of manufacture.<\/p>\n<p><strong>Antibacterial Warnings:\u00a0<\/strong>Use of antibacterial drugs in the absence of a susceptible bacterial infection is unlikely to provide benefit to treated animals and may\u00a0increase the development of drug-resistant bacteria.<\/p>\n<p><strong>User Safety Warnings:\u00a0<\/strong>Not for use in humans. Keep out of reach of children.\u00a0May cause skin irritation. Tylvalosin has been shown to cause hypersensitivity reactions in laboratory animals.\u00a0People with known hypersensitivity to tylvalosin should avoid contact with this product. In case of accidental ingestion or inhalation, seek\u00a0medical attention. When handling Aivlosin 17% Type A Medicated Article and preparing medicated feeds, avoid direct contact with the\u00a0eyes and skin. Wear a dust mask, coveralls and impervious gloves when mixing and handling this product. Eye protection is recommended. In case of accidental eye exposure, wash eyes immediately with water and seek medical attention. If wearing contact lenses, immediately rinse the eyes first, then remove contact lenses and continue to rinse the eyes thoroughly and seek medical attention.\u00a0In case of accidental skin exposure, wash contaminated skin thoroughly.<\/p>\n<p>The Safety Data Sheet contains more detailed occupational safety information.<\/p>\n<hr \/>\n\t\t\t<a href=\"\/wp-content\/uploads\/2018\/03\/Aivlosin-17-VFD-Form-USA-2016.pdf\" target=\"_blank\" rel=\"noopener\">\n\t\t\t\t\t\tSwine\n\t\t\t\t\t<\/a>\n\t\t\t\t<img decoding=\"async\" src=\"https:\/\/pharmgate.com\/wp-content\/uploads\/2023\/01\/aivlosin-17-can-bag-364x500-1.png\" alt=\"aivlosin-17-can-bag-364x500\" itemprop=\"image\" title=\"aivlosin-17-can-bag-364x500\" onerror=\"this.style.display='none'\"  \/>\n\t\t\t\t<img decoding=\"async\" src=\"https:\/\/pharmgate.com\/wp-content\/uploads\/2023\/01\/canada-75x75-1.png\" alt=\"canada-75x75\" itemprop=\"image\" title=\"canada-75x75\" onerror=\"this.style.display='none'\"  \/>\n\t<p>Available in Canada<\/p>\n\t<p><em>The labeling contains complete use information, including any cautions and warnings. Always read, understand and follow the labeling and use directions. See the reverse side for use directions and additional information.<\/em><\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>AIVLOSIN\u00ae 17% (Tylvalosin Medicated Premix)Veterinary use only Product Profile Safety Data Sheet Safety Data Sheet (FR) Product Description Aivlosin\u00ae 17% contains 170 g\/kg tylvalosin\u00a0(supplied as&#8230; <\/p>\n<p><a class=\"bordered-btn read-more-link\" href=\"https:\/\/pharmgate.com\/canada\/aivlosin-17\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":12,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/fullwidthpage.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1467","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Aivlosin 17%<\/title>\n<meta name=\"description\" content=\"Aivlosin is a broad spectrum Tylvalosin Type B medicated feed, effective against both Gram-positive and Gram-negative organisms that can cause swine respiratory disease or swine ileitis.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharmgate.com\/canada\/aivlosin-17\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aivlosin 17%\" \/>\n<meta property=\"og:description\" content=\"Aivlosin is a broad spectrum Tylvalosin Type B medicated feed, effective against both Gram-positive and Gram-negative organisms that can cause swine respiratory disease or swine ileitis.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharmgate.com\/canada\/aivlosin-17\/\" \/>\n<meta property=\"og:site_name\" content=\"Canada\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-17T19:22:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pharmgate.com\/wp-content\/uploads\/2018\/01\/Aivlosin-species-577x75.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pharmgate.com\/canada\/aivlosin-17\/\",\"url\":\"https:\/\/pharmgate.com\/canada\/aivlosin-17\/\",\"name\":\"Aivlosin 17%\",\"isPartOf\":{\"@id\":\"https:\/\/pharmgate.com\/canada\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pharmgate.com\/canada\/aivlosin-17\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pharmgate.com\/canada\/aivlosin-17\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pharmgate.com\/wp-content\/uploads\/2018\/01\/Aivlosin-species-577x75.png\",\"datePublished\":\"2018-03-14T19:36:41+00:00\",\"dateModified\":\"2025-10-17T19:22:33+00:00\",\"description\":\"Aivlosin is a broad spectrum Tylvalosin Type B medicated feed, effective against both Gram-positive and Gram-negative organisms that can cause swine respiratory disease or swine ileitis.\",\"breadcrumb\":{\"@id\":\"https:\/\/pharmgate.com\/canada\/aivlosin-17\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pharmgate.com\/canada\/aivlosin-17\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pharmgate.com\/canada\/aivlosin-17\/#primaryimage\",\"url\":\"https:\/\/pharmgate.com\/wp-content\/uploads\/2018\/01\/Aivlosin-species-577x75.png\",\"contentUrl\":\"https:\/\/pharmgate.com\/wp-content\/uploads\/2018\/01\/Aivlosin-species-577x75.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pharmgate.com\/canada\/aivlosin-17\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pharmgate.com\/canada\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aivlosin 17%\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pharmgate.com\/canada\/#website\",\"url\":\"https:\/\/pharmgate.com\/canada\/\",\"name\":\"Canada\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pharmgate.com\/canada\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aivlosin 17%","description":"Aivlosin is a broad spectrum Tylvalosin Type B medicated feed, effective against both Gram-positive and Gram-negative organisms that can cause swine respiratory disease or swine ileitis.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharmgate.com\/canada\/aivlosin-17\/","og_locale":"en_US","og_type":"article","og_title":"Aivlosin 17%","og_description":"Aivlosin is a broad spectrum Tylvalosin Type B medicated feed, effective against both Gram-positive and Gram-negative organisms that can cause swine respiratory disease or swine ileitis.","og_url":"https:\/\/pharmgate.com\/canada\/aivlosin-17\/","og_site_name":"Canada","article_modified_time":"2025-10-17T19:22:33+00:00","og_image":[{"url":"https:\/\/pharmgate.com\/wp-content\/uploads\/2018\/01\/Aivlosin-species-577x75.png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/pharmgate.com\/canada\/aivlosin-17\/","url":"https:\/\/pharmgate.com\/canada\/aivlosin-17\/","name":"Aivlosin 17%","isPartOf":{"@id":"https:\/\/pharmgate.com\/canada\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharmgate.com\/canada\/aivlosin-17\/#primaryimage"},"image":{"@id":"https:\/\/pharmgate.com\/canada\/aivlosin-17\/#primaryimage"},"thumbnailUrl":"https:\/\/pharmgate.com\/wp-content\/uploads\/2018\/01\/Aivlosin-species-577x75.png","datePublished":"2018-03-14T19:36:41+00:00","dateModified":"2025-10-17T19:22:33+00:00","description":"Aivlosin is a broad spectrum Tylvalosin Type B medicated feed, effective against both Gram-positive and Gram-negative organisms that can cause swine respiratory disease or swine ileitis.","breadcrumb":{"@id":"https:\/\/pharmgate.com\/canada\/aivlosin-17\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharmgate.com\/canada\/aivlosin-17\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharmgate.com\/canada\/aivlosin-17\/#primaryimage","url":"https:\/\/pharmgate.com\/wp-content\/uploads\/2018\/01\/Aivlosin-species-577x75.png","contentUrl":"https:\/\/pharmgate.com\/wp-content\/uploads\/2018\/01\/Aivlosin-species-577x75.png"},{"@type":"BreadcrumbList","@id":"https:\/\/pharmgate.com\/canada\/aivlosin-17\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pharmgate.com\/canada\/"},{"@type":"ListItem","position":2,"name":"Aivlosin 17%"}]},{"@type":"WebSite","@id":"https:\/\/pharmgate.com\/canada\/#website","url":"https:\/\/pharmgate.com\/canada\/","name":"Canada","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharmgate.com\/canada\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/pharmgate.com\/canada\/wp-json\/wp\/v2\/pages\/1467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmgate.com\/canada\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pharmgate.com\/canada\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pharmgate.com\/canada\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmgate.com\/canada\/wp-json\/wp\/v2\/comments?post=1467"}],"version-history":[{"count":2,"href":"https:\/\/pharmgate.com\/canada\/wp-json\/wp\/v2\/pages\/1467\/revisions"}],"predecessor-version":[{"id":9161,"href":"https:\/\/pharmgate.com\/canada\/wp-json\/wp\/v2\/pages\/1467\/revisions\/9161"}],"wp:attachment":[{"href":"https:\/\/pharmgate.com\/canada\/wp-json\/wp\/v2\/media?parent=1467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}